Asgeir S Jakola, MD, PhD
St.Olavs University Hospital and Sahlgrenska University Hospital · Sahlgrenska University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Asgeir S Jakola, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04243005 · Supramarginal Resection in GlioblastomaSt. Olavs Hospital · active not recruiting · Glioblastoma · principal investigator
- Early Ph1NCT03151772 · Bioavailability of Disulfiram and Metformin in GlioblastomasSahlgrenska University Hospital · terminated · Glioblastoma · principal investigator
- Ph2/Ph3NCT02678975 · Disulfiram in Recurrent GlioblastomaSahlgrenska University Hospital · completed · Glioma, Glioblastoma · principal investigator
- N/ANCT01932255 · CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar TapSt. Olavs Hospital · withdrawn · Cranial Nerve Diseases, Facial Neuralgia, Trigeminal Neuralgia
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.